We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-2.21%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$704M
AUM Growth
-$99.5M
Cap. Flow
+$205M
Cap. Flow %
29.06%
Top 10 Hldgs %
90.93%
Holding
52
New
12
Increased
3
Reduced
15
Closed
20

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$23.5M
2
CCRN
Cross Country Healthcare
CCRN
+$1.72M
3
CFRX
ContraFect Corporation
CFRX
+$904K
4
FORA
Forian
FORA
+$188K

Top Sells

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$12.6M
2
AVIR icon
Atea Pharmaceuticals
AVIR
+$10.8M
3
YMAB
Y-mAbs Therapeutics
YMAB
+$9.01M
4
GH icon
Guardant Health
GH
+$8.75M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$7.84M

Sector Composition

Rank Sector Weight
1 Healthcare 96.75%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTNR
51
DELISTED
Vertex Energy, Inc
VTNR
– –
-90,000
Closed -$472K
BHVN
52
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-80,000
Closed -$2.17M
1 2
3

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Oracle Investment Management held 52 positions worth $704M, down 12% from $803M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Oracle Investment Management deployed $205M of net new capital in Q4 2021, opening 12 new positions and adding to 3 existing holdings. Its largest new stake was Pfizer: 475,000 shares worth $28M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 99% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Vir Biotechnology, an estimated $12.6M trimmed.

  • Oracle Investment Management's largest Q4 2021 buy was Pfizer: 475,000 shares worth $28M.
  • Oracle Investment Management added most to ContraFect Corporation in Q4 2021, an estimated $904K increase.
  • Oracle Investment Management's biggest Q4 2021 reduction was Vir Biotechnology, cutting an estimated $12.6M.
  • Oracle Investment Management fully exited Atea Pharmaceuticals in Q4 2021, selling an estimated $10.8M.
  • Oracle Investment Management's ten largest holdings make up 91% of its $704M portfolio in Q4 2021.
  • Oracle Investment Management opened 12 new positions and closed 20 in Q4 2021.
  • Oracle Investment Management's portfolio value fell 12% quarter-over-quarter to $704M.

Based on Oracle Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.